344 related articles for article (PubMed ID: 12899614)
1. Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity.
Stanley TB; Leesnitzer LM; Montana VG; Galardi CM; Lambert MH; Holt JA; Xu HE; Moore LB; Blanchard SG; Stimmel JB
Biochemistry; 2003 Aug; 42(31):9278-87. PubMed ID: 12899614
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha.
Xu HE; Stanley TB; Montana VG; Lambert MH; Shearer BG; Cobb JE; McKee DD; Galardi CM; Plunket KD; Nolte RT; Parks DJ; Moore JT; Kliewer SA; Willson TM; Stimmel JB
Nature; 2002 Feb; 415(6873):813-7. PubMed ID: 11845213
[TBL] [Abstract][Full Text] [Related]
3. Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation.
Krogsdam AM; Nielsen CA; Neve S; Holst D; Helledie T; Thomsen B; Bendixen C; Mandrup S; Kristiansen K
Biochem J; 2002 Apr; 363(Pt 1):157-65. PubMed ID: 11903058
[TBL] [Abstract][Full Text] [Related]
4. Ligand-induced stabilization of PPARgamma monitored by NMR spectroscopy: implications for nuclear receptor activation.
Johnson BA; Wilson EM; Li Y; Moller DE; Smith RG; Zhou G
J Mol Biol; 2000 Apr; 298(2):187-94. PubMed ID: 10764590
[TBL] [Abstract][Full Text] [Related]
5. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma.
Nolte RT; Wisely GB; Westin S; Cobb JE; Lambert MH; Kurokawa R; Rosenfeld MG; Willson TM; Glass CK; Milburn MV
Nature; 1998 Sep; 395(6698):137-43. PubMed ID: 9744270
[TBL] [Abstract][Full Text] [Related]
6. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
[TBL] [Abstract][Full Text] [Related]
7. Coactivator and corepressor complexes in nuclear receptor function.
Xu L; Glass CK; Rosenfeld MG
Curr Opin Genet Dev; 1999 Apr; 9(2):140-7. PubMed ID: 10322133
[TBL] [Abstract][Full Text] [Related]
8. Alternative splicing determines the interaction of SMRT isoforms with nuclear receptor-DNA complexes.
Faist F; Short S; Kneale GG; Sharpe CR
Biosci Rep; 2009 Jun; 29(3):143-9. PubMed ID: 18752469
[TBL] [Abstract][Full Text] [Related]
9. Corepressor recruitment by agonist-bound nuclear receptors.
White JH; Fernandes I; Mader S; Yang XJ
Vitam Horm; 2004; 68():123-43. PubMed ID: 15193453
[TBL] [Abstract][Full Text] [Related]
10. Corepressor binding to progesterone and glucocorticoid receptors involves the activation function-1 domain and is inhibited by molybdate.
Wang D; Simons SS
Mol Endocrinol; 2005 Jun; 19(6):1483-500. PubMed ID: 15774497
[TBL] [Abstract][Full Text] [Related]
11. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
Hodgson MC; Astapova I; Hollenberg AN; Balk SP
Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755
[TBL] [Abstract][Full Text] [Related]
12. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors.
Hu X; Lazar MA
Nature; 1999 Nov; 402(6757):93-6. PubMed ID: 10573424
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity.
Solomon IH; Hager JM; Safi R; McDonnell DP; Redinbo MR; Ortlund EA
J Mol Biol; 2005 Dec; 354(5):1091-102. PubMed ID: 16289203
[TBL] [Abstract][Full Text] [Related]
14. Agonist-antagonist induced coactivator and corepressor interplay on the human androgen receptor.
Dotzlaw H; Papaioannou M; Moehren U; Claessens F; Baniahmad A
Mol Cell Endocrinol; 2003 Dec; 213(1):79-85. PubMed ID: 15062576
[TBL] [Abstract][Full Text] [Related]
15. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.
Wang Q; Blackford JA; Song LN; Huang Y; Cho S; Simons SS
Mol Endocrinol; 2004 Jun; 18(6):1376-95. PubMed ID: 15016838
[TBL] [Abstract][Full Text] [Related]
16. Neuroanatomical distribution and colocalisation of nuclear receptor corepressor (N-CoR) and silencing mediator of retinoid and thyroid receptors (SMRT) in rat brain.
van der Laan S; Lachize SB; Schouten TG; Vreugdenhil E; de Kloet ER; Meijer OC
Brain Res; 2005 Oct; 1059(2):113-21. PubMed ID: 16212947
[TBL] [Abstract][Full Text] [Related]
17. Ski-interacting protein, a bifunctional nuclear receptor coregulator that interacts with N-CoR/SMRT and p300.
Leong GM; Subramaniam N; Issa LL; Barry JB; Kino T; Driggers PH; Hayman MJ; Eisman JA; Gardiner EM
Biochem Biophys Res Commun; 2004 Mar; 315(4):1070-6. PubMed ID: 14985122
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional cofactors exhibit differential preference toward peroxisome proliferator-activated receptors alpha and delta in uterine cells.
Lim HJ; Moon I; Han K
Endocrinology; 2004 Jun; 145(6):2886-95. PubMed ID: 15001550
[TBL] [Abstract][Full Text] [Related]
19. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
[TBL] [Abstract][Full Text] [Related]
20. Tetrabromobisphenol-A disrupts thyroid hormone receptor alpha function in vitro: use of fluorescence polarization to assay corepressor and coactivator peptide binding.
Lévy-Bimbot M; Major G; Courilleau D; Blondeau JP; Lévi Y
Chemosphere; 2012 May; 87(7):782-8. PubMed ID: 22277881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
